Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Elevation Oncology Inc. (Nasdaq: ELEV) is being bought out by Concentra Biosciences for $0.36 in cash per share, plus a ...

“While we would have preferred to reach an agreement privately, Cycle is publicly disclosing our proposal for the benefit of Vanda shareholders,” said the Cambridge, UK-headquartered compan ...

Fable Therapeutics, a discovery-stage biotechnology company developing purpose-built biologics powered by state-of-the-art structure and sequence-based protein language models, today announced the ...

A more sustainable future facilitated by the transforming power of chemistry.